人类胚胎基因组在染色体层面具有复杂性,染色体异常细胞优先定位于远离发育中胎儿的位置
研究对964枚第3天卵裂期胚胎进行单细胞活检和染色体诊断,其中501枚(52%)为非整倍体,174枚发育至囊胚。对174枚囊胚的ICM、TE、Bc和PC分析显示,非整倍体细胞被隔离远离ICM,更多进入Bc和PC。
要点
- 第3天非整倍体胚胎中65%退化,35%(174枚)发育至囊胚,与整倍体胚胎退化率30%差异显著(P<0.0001)。
- 囊胚ICM中(半)一致非整倍体占39%、正常化整倍体占57%、其他非整倍体占3%。
- TE核型预测ICM核型的阳性预测值为86.7%,异常率略高(P=.071)。
核心结论
- 人类胚胎中非整倍体细胞被隔离远离ICM,部分进入TE,但更多进入囊胚腔液和囊胚周围细胞。
- 嵌合型人类卵裂期胚胎可分化为整倍体细胞占优势的整倍体ICM。
研究设计与样本
- 共964枚第3天卵裂期胚胎接受单细胞活检和染色体构成诊断,全部维持培养以评估囊胚形成率。
- 对174枚确诊非整倍体且发育至囊胚的胚胎,分析ICM(全部174枚)、TE(全部174枚)、Bc(47枚)和PC(38枚)的染色体构成。
- 144对夫妇在三个IVF临床环境中接受常规植入前非整倍体遗传学检测,卵裂期活检后行下一代测序。
主要发现
- 964枚胚胎中463枚(48%)第3天诊断为整倍体,其中70%形成囊胚(导致59%妊娠率),30%退化。
- 501枚(52%)诊断为非整倍体,其中65%退化,35%(174枚)形成囊胚,差异高度显著(P<0.0001)。
- 174枚形成囊胚中,(半)一致非整倍体/正常化整倍体/其他非整倍体比例:ICM为39%/57%/3%,TE为49%/48%/3%,PC为78%/21%/0%,Bc为83%/10%/5%。
- TE核型预测ICM核型的阳性预测值为86.7%,异常率略高(P=.071)。
- Bc/PC的异常水平显著高于ICM和TE的倍性(P<0.0001),几乎所有染色体异常至少部分与第3天诊断一致。
临床怎么用
- 作者认为,将非整倍体细胞/核隔离到不再参与胎儿发育的结构,对植入前和产前遗传学检测具有重要意义。
- 作者指出,这些结果挑战了先前对人类早期发育中丝裂保真度的基本理解,并表明人类胚胎基因组具有复杂和流动的特性。
局限性
- 结果仅涉及人类IVF胚胎,因此 extrapolation 到体内情况和其他物种不确定。
- 作者承认除所提出的谱系特异性存活外,囊胚形成期间可能存在其他机制,如谱系特异性细胞移动。
- 伦理考虑使在人类胚胎中研究该机制变得困难。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are chromosome abnormalities detected at Day 3 post-fertilization predominantly retained in structures of the blastocyst other than the inner cell mass (ICM), where chromosomally normal cells are preferentially retained? SUMMARY ANSWER: In human embryos, aneuploid cells are sequestered away from the ICM, partly to the trophectoderm (TE) but more significantly to the blastocoel fluid within the blastocoel cavity (Bc) and to peripheral cells (PCs) surrounding the blastocyst during Day 3 to Day 5 progression. WHAT IS KNOWN ALREADY: A commonly held dogma in all diploid eukaryotes is that two gametes, each with 'n' chromosomes (23 in humans), fuse to form a '2n' zygote (46 in humans); a state that remains in perpetuity for all somatic cell divisions. Human embryos, however, display high levels of chromosomal aneuploidy in early stages that reportedly declines from Day 3 (cleavage stage) to Day 5 (blastocyst) post-fertilization. While this observation may be partly because of aneuploid embryonic arrest before blastulation, it could also be due to embryo 'normalization' to a euploid state during blastulation. If and how this normalization occurs requires further investigation. STUDY DESIGN, SIZE, DURATION: A total of 964 cleavage-stage (Day 3) embryos underwent single-cell biopsy and diagnosis for chromosome constitution. All were maintained in culture, assessing blastulation rate, both for those assessed euploid and aneuploid. Pregnancy rate was assessed for those determined euploid, blastulated and subsequently transferred. For those determined aneuploid and blastulated (174 embryos), ICM (all 174 embryos), TE (all 174), Bc (47 embryos) and PC (38 embryos) were analyzed for chromosome constitution. Specifically, concordance with the original Day 3 diagnosis and determination if any 'normalized' to euploid karyotypes within all four structures was assessed. PARTICIPANTS/MATERIALS, SETTING, METHODS: All patients (144 couples) were undergoing routine preimplantation genetic testing for aneuploidy in three IVF clinical settings. Cleavage-stage biopsy preceded chromosome analysis by next-generation sequencing. All patients provided informed consent. Additional molecular testing was carried out on blastocyst embryos and was analyzed for up to four embryonic structures (ICM, TE, Bc and PC). MAIN RESULTS AND THE ROLE OF CHANCE: Of 463/964 embryos (48%) diagnosed as euploid at Day 3, 70% blastulated (leading to a 59% pregnancy rate) and 30% degenerated. Conversely, of the 501 (52%) diagnosed as aneuploid, 65% degenerated and 35% (174) blastulated, a highly significant difference (P < 0.0001). Of the 174 that blastulated, the ratio of '(semi)concordant-aneuploid' versus 'normalized-euploid' versus 'other-aneuploid' embryos was, respectively, 39%/57%/3% in the ICM; 49%/48%/3% in the TE; 78%/21%/0% in the PC; and 83%/10%/5% in the Bc. The TE karyotype therefore has a positive predictive value of 86.7% in determining that of the ICM, albeit with marginally higher aneuploid rates of abnormalities (P = .071). Levels of abnormality in Bc/PC were significantly higher (P < 0.0001) versus the ploidy of the ICM and TE and nearly all chromosome abnormalities were (at least partially) concordant with Day 3 diagnoses. LIMITATIONS, REASONS FOR CAUTION: The results only pertain to human IVF embryos so extrapolation to the in vivo situation and to other species is not certain. We acknowledge (rather than lineage-specific survival, as we suggest here) the possibility of other mechanisms, such as lineage-specific movement of cells, during blastulation. Ethical considerations, however, make investigating this mechanism difficult on human embryos. WIDER IMPLICATIONS OF THE FINDINGS: Mosaic human cleavage-stage embryos can differentiate into a euploid ICM where euploid cell populations predominate. Sequestering of aneuploid cells/nuclei to structures no longer involved in fetal development has important implications for preimplantation and prenatal genetic testing. These results also challenge previous fundamental understandings of mitotic fidelity in early human development and indicate a complex and fluid nature of the human embryonic genome. STUDY FUNDING/COMPETING INTEREST(S): This research was funded by Organon Pharmaceuticals and Merck Serono by grants to W.G.K. W.G.K. is also an employee of AdvaGenix, who could, potentially, indirectly benefit financially from publication of this manuscript. R.C.M. is supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number R35GM133747. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. D.K.G. provides paid consultancy services for Care Fertility. TRIAL REGISTRATION NUMBER: : N/A.
引用
- Griffin DK, Brezina PR, Tobler K, et al. The human embryonic genome is karyotypically complex, with chromosomally abnormal cells preferentially located away from the developing fetus. Hum Reprod. 2023. PMID: 36350568. doi:10.1093/humrep/deac238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。